发明名称 |
Methods and compositions related to immunizing against <i>Staphylococcal </i>lung disease and conditions |
摘要 |
Embodiments of the invention include methods and compositions useful in a vaccination strategy capable of neutralizing HIa to provide immunoprotection against S. aureus pneumonia. In certain aspects the invention includes a HIa with reduced toxicity, represented by a recombinant mutant form of HIa (HlaH35L) in which histidine 35 is converted to leucine, which can be used to abrogate the productive assembly of the toxin and protect a subject from staphylococcal pneumonia. |
申请公布号 |
US8840906(B2) |
申请公布日期 |
2014.09.23 |
申请号 |
US200812675597 |
申请日期 |
2008.08.29 |
申请人 |
The University of Chicago |
发明人 |
Bubeck-Wardenburg Juliane;Schneewind Olaf;Ragle Brook |
分类号 |
A61K39/00;A61K39/02;A61K39/38;A61K39/085;A61K39/09;A61K45/00;A61K47/00;C07K16/12 |
主分类号 |
A61K39/00 |
代理机构 |
Fulbright & Jaworski LLP |
代理人 |
Fulbright & Jaworski LLP |
主权项 |
1. A method of eliciting an immune response in a patient to a staphylococcal bacteria, wherein the patient is hospitalized or will be hospitalized or the patient will undergo surgery and/or be anesthetized, comprising administering to a patient an effective amount of a composition comprising a purified recombinant and attenuated Staphylococcus α-hemolysin (Hla) toxin, wherein the composition contains no more than contaminating amounts of any other Staphylococcus protein. |
地址 |
Chicago IL US |